Dabbs E R, Looman K
Mol Gen Genet. 1981;184(2):224-9. doi: 10.1007/BF00272909.
A conditioned lethal mutant of E. coli was isolated which required the presence of either the RNA polymerase targeted antibiotic, rifampicin, or the ribosomally targeted antibiotic, kasugamycin, for survival. This mutant was characterised. The locus of the mutation responsible for the antibiotic dependent phenotype, ridA, was mapped at about 70.5 min on the chromosomal linkage map, between argR and fabE. The mutant was investigated as a candidate for a strain with a lesion in some cellular component acting on both RNA polymerase and the ribosome. A close interaction with RNA polymerase was evident from the interplay arising from the combination of ridA and various rpoB mutations as manifested in the phenotype. The ability of kasugamycin, but not other ribosomally targeted aminoglycoside antibiotics, to relieve the lethality due to the ridA mutation was an indication of the specificity in the interaction of the ridA gene product with the ribosome.
分离出一种大肠杆菌条件致死突变体,该突变体需要存在靶向RNA聚合酶的抗生素利福平或靶向核糖体的抗生素春日霉素才能存活。对该突变体进行了表征。将导致抗生素依赖性表型的突变位点ridA定位在染色体连锁图谱上约70.5分钟处,位于argR和fabE之间。对该突变体作为一种在作用于RNA聚合酶和核糖体的某些细胞成分中存在损伤的菌株候选进行了研究。从ridA与各种rpoB突变组合产生的表型相互作用中可以明显看出与RNA聚合酶的密切相互作用。春日霉素而非其他靶向核糖体的氨基糖苷类抗生素缓解ridA突变致死性的能力表明ridA基因产物与核糖体相互作用具有特异性。